Gatechompol, Sivaporn
Lutter, René
Vaz, Frédéric M.
Ubolyam, Sasiwimol
Avihingsanon, Anchalee
Kerr, Stephen J.
van Leth, Frank
Cobelens, Frank
Funding for this research was provided by:
HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand
Department of Experimental Immunology, Amsterdam UMC and Amsterdam Infection and Immunity Institute, University of Amsterdam, Amsterdam, The Netherlands
Department of Core Facility Metabolomics, Amsterdam UMC, Amsterdam, The Netherlands.
Department of Health Sciences, Vrije Universiteit Amsterdam, Amsterdam Public Health research institute, Amsterdam, The Netherlands
Department of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centers location University of Amsterdam, Amsterdam, The Netherlands.
Article History
Received: 28 September 2023
Accepted: 26 March 2024
First Online: 2 April 2024
Declarations
:
: The study protocol was approved by the medical ethics committee, Faculty of Medicine, Chulalongkorn University, Bangkok (IRB No.161/45) and conducted in accordance with Good Clinical Practice guidelines and the principles of the Declaration of Helsinki. All participants in HN006 cohort provided written informed consent and consented for the use of plasma stored samples in this study.
: Not applicable.
: The authors declare no competing interests.